Researchers with the Alzheimer’s Disease Neuroimaging Initiative, a five-year, nationwide, longitudinal study of possible markers of Alzheimer’s disease, announced that a genomic analysis of the 800 participants in the study is more than 95 percent complete, and that the data will be shared with scientists around the world for further analysis.